Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Stijn Groten"'
Autor:
Lodewyk F. A. Wessels, René Bernards, Lisanne de la Fonteijne, Sara Mainardi, Gianluca Maddalo, Edwin Cuppen, Albert J. R. Heck, Anna Ressa, Myrthe Jager, A. F. Maarten Altelaar, Joep de Ligt, Martin Fitzpatrick, Anirudh Prahallad, Stijn Groten, Evert Bosdriesz
Publikováno v:
Ressa, A, Bosdriesz, E, de Ligt, J, Mainardi, S, Maddalo, G, Prahallad, A, Jager, M, de la Fonteijne, L, Fitzpatrick, M, Groten, S, Altelaar, A F M, Bernards, R, Cuppen, E, Wessels, L & Heck, A J R 2018, ' A System-wide Approach to Monitor Responses to Synergistic BRAF and EGFR Inhibition in Colorectal Cancer Cells ', Molecular and Cellular Proteomics, vol. 17, no. 10, pp. 1892-1908 . https://doi.org/10.1074/mcp.RA117.000486
Molecular and Cellular Proteomics, 17(10), 1892-1908. American Society for Biochemistry and Molecular Biology Inc.
Molecular & Cellular Proteomics, 17(10), 1892. American Society for Biochemistry and Molecular Biology Inc.
Molecular and Cellular Proteomics, 17(10), 1892-1908. American Society for Biochemistry and Molecular Biology Inc.
Molecular & Cellular Proteomics, 17(10), 1892. American Society for Biochemistry and Molecular Biology Inc.
Intrinsic and/or acquired resistance represents one of the great challenges in targeted cancer therapy. A deeper understanding of the molecular biology of cancer has resulted in more efficient strategies, where one or multiple drugs are adopted in no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afb2b62d6a87d2d6f8cfd017c5019cba
https://dspace.library.uu.nl/handle/1874/377105
https://dspace.library.uu.nl/handle/1874/377105
Autor:
A. F. Maarten Altelaar, Myrthe Jager, Stijn Groten, Lisanne de la Fonteijne, Lodewyk F. A. Wessels, Albert J. R. Heck, Martin Fitzpatrick, Joep de Ligt, Gianluca Maddalo, Evert Bosdriesz, Sara Mainardi, Anna Ressa, Edwin Cuppen, Anirudh Prahallad, René Bernards
Publikováno v:
SSRN Electronic Journal.
Intrinsic and/or acquired resistance represents one of the great challenges in targeted cancer therapy. A deeper understanding of the molecular biology of cancer has resulted in more efficient strategies, where one or multiple drugs are adopted in no